ribavirin has been researched along with Communicable Diseases in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Averbuch, D; Bierings, M; Blijlevens, N; Bruns, A; Cornelissen, JJ; de la Camara, R; Diaz, MA; Ghesquieres, H; Knelange, N; Koenecke, C; Kroger, N; Labussiere-Wallet, H; Mikulska, M; Passweg, J; Penack, O; Piñana, JL; Sampol, A; Styczynski, J; Wendel, L | 1 |
| Muangman, N; Sunhapanit, S; Wongsurakiat, P | 1 |
| Diepolder, H | 1 |
| Falsey, AR | 1 |
| Kimpen, JL; Schaad, UB | 1 |
2 review(s) available for ribavirin and Communicable Diseases
| Article | Year |
|---|---|
[Hepatitis E - an underestimated infectious disease].
Topics: Antiviral Agents; Communicable Diseases; Hepatitis E; Humans; Ribavirin | 2019 |
Respiratory syncytial virus infection in adults.
Topics: Aged; Aged, 80 and over; Antiviral Agents; Asthma; Communicable Disease Control; Communicable Diseases; Cross Infection; Homes for the Aged; Humans; Middle Aged; Nursing Homes; Pneumonia, Viral; Pulmonary Disease, Chronic Obstructive; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus Vaccines; Respiratory Syncytial Virus, Human; Ribavirin | 2007 |
3 other study(ies) available for ribavirin and Communicable Diseases
| Article | Year |
|---|---|
HEV infection in stem cell transplant recipients-retrospective study of EBMT Infectious Diseases Working Party.
Topics: Communicable Diseases; Hepatitis E virus; Humans; Immunocompromised Host; Retrospective Studies; Ribavirin; RNA; Stem Cell Transplantation; Transplant Recipients | 2022 |
Respiratory syncytial virus-associated acute respiratory illness in adult non-immunocompromised patients: Outcomes, determinants of outcomes, and the effect of oral ribavirin treatment.
Topics: Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Antiviral Agents; Communicable Diseases; Humans; Immunocompromised Host; Middle Aged; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human; Retrospective Studies; Ribavirin | 2022 |
Treatment of respiratory syncytial virus bronchiolitis: 1995 poll of members of the European Society for Paediatric Infectious Diseases.
Topics: Adrenal Cortex Hormones; Adult; Antiviral Agents; Bronchiolitis, Viral; Bronchodilator Agents; Communicable Diseases; Humans; Infant; Policy Making; Population Surveillance; Program Evaluation; Respiratory Syncytial Virus Infections; Ribavirin; Surveys and Questionnaires | 1997 |